BR9912024A - Emplastros em gel contento esteróide e processo para a produção dos mesmos - Google Patents

Emplastros em gel contento esteróide e processo para a produção dos mesmos

Info

Publication number
BR9912024A
BR9912024A BR9912024-0A BR9912024A BR9912024A BR 9912024 A BR9912024 A BR 9912024A BR 9912024 A BR9912024 A BR 9912024A BR 9912024 A BR9912024 A BR 9912024A
Authority
BR
Brazil
Prior art keywords
production
steroid
blended
weight
containing steroid
Prior art date
Application number
BR9912024-0A
Other languages
English (en)
Inventor
Kazunori Muta
Seiichiro Tsuru
Taro Yamahata
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Publication of BR9912024A publication Critical patent/BR9912024A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Patente de Invenção: <B>"EMPLASTROS EM GEL CONTENDO ESTERóIDE E PROCESSO PARA A PRODUçãO DOS MESMOS"<D>. Emplastro em gel contendo esteróide contendo um esteróide como um ingrediente eficaz a 0,005 a 0,05% em peso, crotamitona como um estabilizador a 15% em peso ou menos e um tensoativo em uma base, onde a quantidade da crotamitona misturada é de 200 a 3000 vezes o peso do esteróide misturado e a quantidade do tensoativo misturado é de 1/20 a 1/5 vezes o peso da crotamitona misturada.
BR9912024-0A 1998-07-10 1999-07-07 Emplastros em gel contento esteróide e processo para a produção dos mesmos BR9912024A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19593398A JP4456679B2 (ja) 1998-07-10 1998-07-10 ステロイド含有パップ剤及びその製造方法
PCT/JP1999/003673 WO2000002563A1 (fr) 1998-07-10 1999-07-07 Cataplasmes contenant des steroides et procede de fabrication associe

Publications (1)

Publication Number Publication Date
BR9912024A true BR9912024A (pt) 2001-05-29

Family

ID=16349396

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9912024-0A BR9912024A (pt) 1998-07-10 1999-07-07 Emplastros em gel contento esteróide e processo para a produção dos mesmos

Country Status (11)

Country Link
US (1) US6432431B1 (pt)
EP (1) EP1097712B1 (pt)
JP (1) JP4456679B2 (pt)
KR (1) KR20010072664A (pt)
CN (1) CN1308537A (pt)
AT (1) ATE250930T1 (pt)
BR (1) BR9912024A (pt)
DE (1) DE69911788T2 (pt)
ES (1) ES2209456T3 (pt)
ID (1) ID27765A (pt)
WO (1) WO2000002563A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3655781B2 (ja) * 1999-08-25 2005-06-02 帝國製薬株式会社 ビタミンｃ又はその誘導体を配合したパップ剤
JP5300038B2 (ja) * 2000-03-07 2013-09-25 株式会社 資生堂 皮膚外用剤
BR0110799A (pt) * 2000-05-15 2003-02-11 Hisamitsu Pharmaceutical Co Máscaras do tipo folha
WO2001091757A1 (fr) * 2000-05-31 2001-12-06 Nichiban Co., Ltd. Preparation streroide du type a absorption percutanee pour usage externe
AU2001264256B2 (en) * 2000-06-13 2006-05-11 Hisamitsu Pharmaceutical Co, Inc Plaster
DE10260872B4 (de) * 2002-12-23 2013-09-26 Beiersdorf Ag Verwendung von gelbildendem Polymer, Wasser, Alkohol und Meeresalgenextrakt zur Einstellung von Elastizität und Haftvermögen selbstklebender kosmetischer Polymermatrices
DE10260873A1 (de) 2002-12-23 2004-07-15 Beiersdorf Ag Selbstklebende Polymermatrix mit einem Gehalt an Meeresalgenextrakt und Glycerin
US7993654B2 (en) 2002-12-23 2011-08-09 Beiersdorf Ag Self-adhesive polymer matrix containing sea algae extract
AU2004208596C1 (en) * 2003-01-28 2012-01-19 Teikoku Seiyaku Co., Ltd Thin aqueous cataplasm
US7998590B2 (en) 2004-04-28 2011-08-16 Hisamitsu Pharmaceutical Co., Inc. Adhesive material
JP4744439B2 (ja) * 2004-04-28 2011-08-10 久光製薬株式会社 貼付剤
JP4824336B2 (ja) * 2004-05-07 2011-11-30 ロート製薬株式会社 皮膚外用剤
JP4824337B2 (ja) * 2004-05-07 2011-11-30 ロート製薬株式会社 皮膚外用剤
WO2006051818A1 (ja) * 2004-11-10 2006-05-18 Hisamitsu Pharmaceutical Co., Inc. 外用製剤及び貼付剤
CN103830179B (zh) * 2014-03-24 2015-11-18 段懿玲 一种含有克罗米通的外用制剂及其制备工艺
CN104984385B (zh) * 2015-07-23 2017-08-29 山东维赫生物科技有限公司 一种水溶性医用预粘剂
TWI833741B (zh) * 2018-03-30 2024-03-01 日商樂敦製藥股份有限公司 外用油性固形組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5842168B2 (ja) * 1974-12-20 1983-09-17 トウコウヤクヒンコウギヨウ カブシキガイシヤ 局所用剤の製造方法
JPS5850964B2 (ja) * 1978-03-07 1983-11-14 東興薬品工業株式会社 ステロイド含有クリ−ム製剤およびその製造方法
JPS58225009A (ja) * 1982-06-23 1983-12-27 Shionogi & Co Ltd コルチコステロイド外用製剤
JPH0236572B2 (ja) * 1984-11-13 1990-08-17 Hokuriku Pharmaceutical Suteroidoo177monoesuteruganjukuriimuzai
JPS6351330A (ja) 1986-08-20 1988-03-04 Teikoku Seiyaku Kk ステロイド剤含有外用貼付剤
JPS63201119A (ja) * 1987-02-17 1988-08-19 Kao Corp 貼付剤組成物
JPH0676327B2 (ja) * 1987-04-14 1994-09-28 株式会社大塚製薬工場 ステロイド軟膏製剤
JPH05271077A (ja) 1992-03-25 1993-10-19 Lion Corp パップ剤
JP3029964B2 (ja) 1993-01-20 2000-04-10 久光製薬株式会社 ステロイド類溶解剤及びステロイド類を主剤とする外用液剤
JP2860748B2 (ja) 1993-12-24 1999-02-24 エスエス製薬株式会社 安定な酪酸ヒドロコルチゾン含有クリーム剤
JPH0853354A (ja) 1994-08-11 1996-02-27 Hisamitsu Pharmaceut Co Inc 皮膚疾患用水性貼付剤
AU692944B2 (en) * 1994-11-18 1998-06-18 Hisamitsu Pharmaceutical Co., Inc. Percutaneously absorbable patch

Also Published As

Publication number Publication date
ATE250930T1 (de) 2003-10-15
KR20010072664A (ko) 2001-07-31
US6432431B1 (en) 2002-08-13
DE69911788T2 (de) 2004-05-06
DE69911788D1 (de) 2003-11-06
EP1097712A4 (en) 2002-05-02
ES2209456T3 (es) 2004-06-16
WO2000002563A1 (fr) 2000-01-20
CN1308537A (zh) 2001-08-15
EP1097712B1 (en) 2003-10-01
JP4456679B2 (ja) 2010-04-28
EP1097712A1 (en) 2001-05-09
JP2000026299A (ja) 2000-01-25
ID27765A (id) 2001-04-26

Similar Documents

Publication Publication Date Title
BR9912024A (pt) Emplastros em gel contento esteróide e processo para a produção dos mesmos
PT1311285E (pt) Composicao farmaceutica liquida contendo um derivado de eritropoietina
BR9406080A (pt) Compostos que tem tanto antividade de anaonista potente de calcio como de antioxidante e uso dos mesmos como agentes citoprotetores
ES2176502T3 (es) Derivados de hidroxilamina utiles para mejorar la pproduccion de chaperonas moleculares su su preparacion.
BRPI0009956A (pt) composição farmacêutica não aquosa para uso dermatológico compreendendo calcipotriol e betametasona, e, uso da mesma
PT1073470E (pt) Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos
BRPI0113757B8 (pt) derivados de quinolinona como inibidores de tirosina quinase
PT804252E (pt) Agentes queladores metalicos que contem monoaminas diamidas e tiois
BR9811099A (pt) Inibidores de urocinase
BRPI0411500A (pt) pesticida para aplicar um aniquilamento de modo de ação fìsica, composição hidrocoloidal, método de aniquilamento de pestes em plantas pelo modo fìsico de operação e processo para a preparação de um pesticida
BR0015416A (pt) Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos
BR0011831A (pt) Compostos, processo para preparar os mesmos, composições farmacêuticas, e, uso dos compostos
ATE253820T1 (de) Wirkstoffhaltige komposition sowie deren herstellung und verwendung
BR9807145A (pt) 2-metoxiimino-2-(piridiniloximetil) fenilacetamidas com derivados de ácido carboxìlico no anel de piridina como fungicidas.
BR9913718A (pt) Processo e composição farmacêutica ou veterinária para inibição profilática ou terapêutica de um material ou substância tóxica em um paciente animal humano ou não-humano, e, uso de um dendrìmero aniÈnico ou catiÈnico
AR013163A1 (es) Uso de composiciones que contienen diclorofenil imidazoldioxolano para la preparacion de un medicamento para tratar la dermatitis seborreica, caspa,psoriasis y acne, composiciones propiamente dichas, y un articulo de fabricacion que contiene dicha composicion
BR9808956A (pt) Composição pesticida
BR9814284A (pt) Composições e métodos para regulação de fagocitose e expressão de icam-1
ATE83668T1 (de) Pflaster zur transdermalen anwendung.
BR0312179A (pt) Processo para preparação de derivado de epik5-n-o-supersulfato, composição farmacêutica e composição cosmética contendo o mesmo e seu uso
AR016044A1 (es) Composiciones farmaceuticas que comprenden cantidades antialergenicas efectivas de descarboniletoxiloratadina
DK0742214T3 (da) I hjerte-kar-systemet aktive, nye seco-D steroider samt farmaceutiske præparater indeholdende sådanne
ES2132283T3 (es) Derivados n-heteroaril sustituidos de propanamida utiles en el tratamiento de enfermedades cardiovasculares.
DE69801811D1 (de) Alkykendiamin di- oder tri-essigsäurederivate, verfahren zu ihrer herstellung und ihre verwendung in kosmetischen zusammensetzungen
BR0308633A (pt) Composições, métodos para bioestimular as agrìcolas, e, uso das composições

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007.